Negredo Eugenia, Domingo Pere, Gutiérrez Félix, Galindo María José, Knobel Hernando, Lozano Fernando, Martínez Esteban, Masiá Mar, Polo Rosa, Estrada Vicente
Lluita contra la Sida Foundation, Germans Trias i Pujol University Hospital, Badalona, Spain; Universitat Autònoma de Barcelona, Barcelona, Spain; Universitat de Vic-Universitat Central de Catalunya, Vic, Barcelona, Spain.
Hospitals Universitaris Arnau de Vilanova & Santa Maria, Universitat de Lleida, Institut de Recerca Biomédica (IRB) de Lleida, Lleida, Spain.
Enferm Infecc Microbiol Clin (Engl Ed). 2018 May;36(5):312-314. doi: 10.1016/j.eimc.2017.03.010. Epub 2017 May 31.
Osteoporosis has become an emerging comorbid condition in people living with HIV (PLWH). The increase in survival and the progressive aging of PLWH will make this complication more frequent in the near future. In addition to the traditional risk factors affecting the general population, factors directly or indirectly associated with HIV infection, including antiretroviral therapy, can increase the risk of osteoporosis. The present article is an executive summary of the document that updates the previous recommendations on the prevention and treatment of osteoporosis in PLWH. This document is intended for all professionals who work in clinical practice in the field of HIV infection.
骨质疏松症已成为艾滋病病毒感染者(PLWH)中一种新出现的合并症。艾滋病病毒感染者生存率的提高以及年龄的不断增长,将使这种并发症在不久的将来更为常见。除了影响普通人群的传统风险因素外,与艾滋病病毒感染直接或间接相关的因素,包括抗逆转录病毒疗法,都可能增加骨质疏松症的风险。本文是一份文件的执行摘要,该文件更新了此前关于艾滋病病毒感染者骨质疏松症预防和治疗的建议。本文件面向所有从事艾滋病病毒感染临床实践领域工作的专业人员。